Capital Raising expertise
Ashurst has pre-eminent global equity and debt capital markets practices and extensive experience in advising on ECM and DCM transactions of all sizes, across a diverse range of sectors and markets.
Our global ECM and DCM teams consist of local capital markets experts based in the major global listing venues, who work closely with our highly experienced US, UK and Asia Pacific capital markets lawyers. They have experience advising on IPOs, secondary offerings, rights issues, private placings and block trades, as well as advising on convertibles and equity derivatives transactions.
They also have experience advising on the issue of various types of regulatory capital instruments, including obtaining pre-issue approvals from local regulators.
Comprehensive offering
We offer a complete service advising on IPOs, secondary offerings, rights issues, private placings and block trades, as well as advising on convertibles and equity derivatives transactions.
Business experts
We have extensive experience advising various life insurers on tier 1 and tier 2 capital raisings, we have advised on one of the first ancillary own funds structures to be approved by the PRA under Solvency II.
Global focus
Our experience includes advising on landmark deals around the world including advising Genworth, the monoline mortgage insurer in Australia, on its IPO, as well as a global syndicate of banks on the e-Sure IPO.
Our experience includes advising:
Barclays Bank and Numis on Sabre Insurance's IPO, one of the biggest in the UK market in 2017
Genworth in respect of its IPO, the first IPO of a monoline lender’s mortgage insurer in Australia
Pacific Life Re in relation to Solvency II-compliant ancillary own funds
The Syndicate for the e-Sure IPO, which comprised Deutsche Bank, JPMorgan Cazenove, Canaccord Genuity and Numis Securities
Challenger in relation to regulatory capital raisings
